Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Huang N, Shi X, Lei B, Wei W, Lu Z, Yu P, et al. An update of the appropriate treatment strategies in anaplastic thyroid cancer: a population-based study of 735 patients. Int J Endocrinol. 2019;2019:1–7.
2. Shelly D, Gupta D, Mishra S, Bharadwaj R. Osteoclastic variant of anaplastic thyroid carcinoma: a case report of rare entity. J Cancer Res Ther. 2019;15(3):704–07
3. Ragazzi M, Ciarrochi A, Sancisi V, Gandolfi G, Bisagni A, Piana S. Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer. Int J Endocrinol. 2014;2014:1–13.
4. Gaumann A, Hansen T, Kohler H, Kommoss F, Mann W, Maurer J, et al. The expression of cathepsins in osteoclast-like giant cells of an anaplastic thyroid carcinoma with tracheal perforation. Pathol Res Pract. 2001;197:257–62.
5. Deeken-Draisey A, Yang GY, Gao J, Alexiev BA. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single – institution study. Hum Pathol. 2018;82:140–8.